Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Green Growth Group Inc.
Greenhouse Naturals LLC
Ermont Inc.
Common stock
Common stock
Green Growth Group Inc.
Common stock
Greenhouse Naturals LLC
Common stock
Ermont Inc.
Common stock subscribed but not issued
Additional paid-in capital
Additional paid-in capital
Green Growth Group Inc.
Additional paid-in capital
Greenhouse Naturals LLC
Additional paid-in capital
Ermont Inc.
Accumulated deficit
Non-controlling interests
Beginning balance (in shares) at Dec. 31, 2021         334,030,348       0            
Beginning balance at Dec. 31, 2021 $ 36,299       $ 334       $ 0 $ 134,920       $ (97,392) $ (1,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of subscribed shares (in shares)         70,000                    
Issuance of subscribed shares 39                            
Release of shares under stock grants (in shares)         402,203                    
Release of shares under stock grants 0                 0          
Exercise of stock options (in shares)         55,000                    
Exercise of stock options 10                 10          
Cashless exercise of stock options (in shares)         200,000                    
Cashless exercise of warrants (in shares)         317,298                    
Forfeiture of restricted shares (in shares)         (32,609)                    
Conversion of promissory notes to common stock (in shares)         1,142,858                    
Conversion of promissory notes to common stock 400       $ 1         399          
Common stock issued to settle obligations (in shares)         375,000                    
Common stock issued to settle obligations 275                 275          
Common stock issued under licensing agreement (in shares)         218,345                    
Common stock issued under licensing agreement 121                 121          
Common stock issued to purchase property and equipment (in shares)         422,535                    
Common stock issued to purchase property and equipment 300       $ 1         299          
Common stock issued as purchase consideration (in shares)           2,343,750 2,000,000                
Common stock issued as purchase consideration   $ 1,500 $ 712     $ 3 $ 2       $ 1,497 $ 710      
Purchase of minority interest in a subsidiary of the Company (2,000)                 (2,165)         165
Distributions to noncontrolling interests (259)                           (259)
Stock-based compensation (in shares)                 70,000            
Stock-based compensation 6,338               $ 39 6,299          
Net income 13,614                         13,468 146
Ending balance (in shares) at Dec. 31, 2022         341,474,728       70,000            
Ending balance at Dec. 31, 2022 57,310       $ 341       $ 39 142,365       (83,924) (1,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common stock subscribed but not issued (in shares)                 5,025            
Common stock subscribed but not issued 2               $ 2            
Issuance of subscribed shares (in shares)         75,025       (75,025)            
Issuance of subscribed shares 0               $ (41) 41          
Release of shares under stock grants (in shares)         599,999                    
Release of shares under stock grants $ 0       $ 1         (1)          
Exercise of stock options (in shares) 487,752       487,752                    
Exercise of stock options $ 109                 109          
Warrants issued in connection with debt 5,454                 5,454          
Conversion of preferred stock to common stock (in shares)         25,304,710                    
Conversion of preferred stock to common stock 18,725       $ 25         18,700          
Common stock issued to settle obligations (in shares)         400,000                    
Common stock issued to settle obligations 160                 160          
Common stock issued under licensing agreement (in shares)         13,007                    
Common stock issued under licensing agreement 5                 5          
Common stock issued to purchase property and equipment (in shares)         740,741                    
Common stock issued to purchase property and equipment 300       $ 1         299          
Common stock issued as purchase consideration (in shares)               6,580,390              
Common stock issued as purchase consideration       $ 2,994       $ 7         $ 2,987    
Purchase of minority interest in a subsidiary of the Company (in shares)         450,000                    
Purchase of minority interest in a subsidiary of the Company 0       $ 1         4         (5)
Common stock returned to the Company in connection with a cancelled transaction (in shares)         (1,000,000)                    
Common stock returned to the Company in connection with a cancelled transaction 0       $ (1)         1          
Distributions to noncontrolling interests (158)                           (158)
Stock-based compensation (in shares)                 0            
Stock-based compensation 1,020               $ 0 1,020          
Net income (16,007)                         (16,031) 24
Ending balance (in shares) at Dec. 31, 2023         375,126,352       0            
Ending balance at Dec. 31, 2023 $ 69,914       $ 375       $ 0 $ 171,144       $ (99,955) $ (1,650)